Droperidol has comparable clinical efficacy against both nausea and vomiting.

Creative Commons License

Apfel C. C., Cakmakkaya Ö. S., Frings G., Kranke P., Malhotra A., Stader A., ...Daha Fazla

British journal of anaesthesia, cilt.103, sa.3, ss.359-63, 2009 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 103 Sayı: 3
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1093/bja/aep177
  • Dergi Adı: British journal of anaesthesia
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.359-63
  • Anahtar Kelimeler: anaesthesia, day-case, PONV, POSTOPERATIVE NAUSEA, PREVENTION, INTERVENTIONS, SINGLE, TRIAL
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

Background. Droperidol is commonly noted to be more effective at preventing postoperative nausea (PON) than vomiting (POV) and it is assumed to have a short duration of action. This may be relevant for clinical decisions, especially for designing multiple-drug antiemetic regimens.